{"DataElement":{"publicId":"65173","version":"3","preferredName":"Upper GI Tumor Clinical M Stage","preferredDefinition":"the absence or presence of distant metastases from upper GI cancer as determined prior to treatment based on evidence obtained from clinical assessment parameters (physical examination, imaging, endoscopy, biopsy, surgical exploration, etc.).","longName":"UPPERGI_TUMOR_C_M_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192274","version":"1","preferredName":"Upper GI Tumor Clinical M Stage","preferredDefinition":"information related to clinical M stage for an upper GI tumor.","longName":"UPPERGI_TUMOR_C_M","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206811","version":"1","preferredName":"Upper GI Neoplasm","preferredDefinition":"Upper Gastrointestinal Tract Radiography is an x-ray examination of the esophagus, stomach and first part of the small intestine following coating with barium solution via ingestion.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C17639:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Gastrointestinal Series","conceptCode":"C17639","definition":"An x-ray examination of the esophagus, stomach and first part of the small intestine following coating with barium solution via ingestion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0575-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9154C85-8A28-0576-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018455","version":"1","preferredName":"Upper GI Tumor Clinical M Stage","preferredDefinition":"the clinical M (metastasis) stage for an upper GI (gastrointestinal) tumor, including pancreas and esophagus.","longName":"UPPERGI_TUMOR_C_M_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M0","valueDescription":"NO DISTANT METASTASES ACCORDING TO AJCC GUIDELINES","ValueMeaning":{"publicId":"2559520","version":"1","preferredName":"NO DISTANT METASTASES ACCORDING TO AJCC GUIDELINES","longName":"2559520","preferredDefinition":"NO DISTANT METASTASES ACCORDING TO AJCC GUIDELINES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B58D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5C944C9-932F-2693-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M1","valueDescription":"DISTANT METASTASES PRESENT ACCORDING TO AJCC GUIDELINES","ValueMeaning":{"publicId":"2558672","version":"1","preferredName":"DISTANT METASTASES PRESENT ACCORDING TO AJCC GUIDELINES","longName":"2558672","preferredDefinition":"DISTANT METASTASES PRESENT ACCORDING TO AJCC GUIDELINES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B23D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5C944C9-9331-2693-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"MX","valueDescription":"DISTANT METASTASES PRESENCE OR ABSENCE CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES","ValueMeaning":{"publicId":"2558671","version":"1","preferredName":"DISTANT METASTASES PRESENCE OR ABSENCE CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES","longName":"2558671","preferredDefinition":"DISTANT METASTASES PRESENCE OR ABSENCE CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B23C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5C944C9-9333-2693-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-03","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B44C275D-0939-498D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-15","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-15","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":"6/21 - values added that were omitted during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"M Stage, Clinical","url":null,"context":"CTEP"},{"name":"Clinical M Stage","type":"Preferred Question Text","description":"Clinical M Stage","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B45F4642-EFA4-016E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-16","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-16","modifiedBy":"REEVESD","dateModified":"2011-04-05","changeDescription":"ISO 11179 Compliance; values added that were omitted during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}